Related Experiment Video
Updated: Nov 5, 2025

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
Smoking Cessation Considerations for People with Multiple Sclerosis.
Christa Brooker1, Myla D Goldman2, S Ross Tingen2
1Department of Pharmacy, University of Virginia Health.
Many multiple sclerosis patients are unaware of smoking's impact on their disease. Integrating smoking cessation support, including clinical pharmacists, is crucial for improving patient outcomes and managing multiple sclerosis progression.
Area of Science:
- Neurology
- Public Health
- Pharmacology
Background:
- Cigarette smoking is a modifiable risk factor linked to multiple sclerosis (MS) development, progression, and increased disability.
- Limited understanding exists regarding factors influencing smoking cessation in MS patients and its integration into specialized care.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Stress Prevention and Stress Management Techniques IV
CNS Depressants: Alcohol and Nicotine
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
COPD: Management Using Bronchodilators and Corticosteroids

